06/05/2023 / Northwestern Medicine
Northwestern Medicine investigators have shown that inhibiting a mutated gene can reduce seizure activity in adult-type diffuse gliomas
06/02/2023 / Neurology Today
“We need to come together as a community and begin to discuss what’s out there, set standards, and lay down some guidelines,”
06/02/2023 / Health Science Journalism
New research has shown for the first time how the commonly prescribed seizure and pain medication, gabapentin, acts inside of cells, opening the door to new, more effective treatments for diseases like epilepsy and Lupus.
06/02/2023 / Physician's Weekly
The Medtronic Registry for Epilepsy (MORE) aims to assess ANT DBS therapy’s safety and longer-term effectiveness in routine clinical practice.
06/01/2023 /
Epilepsy Awareness Night with the Chicago White Sox, our mental health webinar, and more in this Update.
05/31/2023 / AJMC
Early identification of children who will develop epilepsy after a CFS is essential to future management and counseling for parents/caregivers
05/30/2023 / Neurology Advisor
The prevalence of seizures roughly doubles between the ages of 50 and 80 years. More than 95% of patients with epilepsy are treated with ASMs as they are effective at preventing recurrent seizures; however, older adults may be vulnerable to the side effects of ASMs.
05/26/2023 / Dravet Syndrome News
Up to 1 in 4 people with hard-to-treat epilepsy, including those with Dravet syndrome, were found to stop taking Epidiolex (cannabidiol) shortly after starting treatment, primarily due to side effects or a lack of efficacy, according to a real-world study.
05/25/2023 / NBC
A new study finds that some infants who die of SIDS have abnormalities in a particular brain receptor that may be involved in helping them gasp for air.
